Summary
Machine-generated summaryThe contracting authority is running a framework agreement for the supply of oncology medicines, divided into 16 lots, in line with the tender specifications. Medicines include cytotoxic and monoclonal antibody products such as cetuximab, pertuzumab, cabazitaxel, docetaxel, paclitaxel, liposomal doxorubicin and trastuzumab, with minimum and maximum framework quantities set per product. The framework agreements enter into force on the date stated for each lot in the additional information section. The buyer reserves the right to terminate if the Ministry of National Defence or another institution procures these products centrally for the Constanța military hospital. Clarification requests must be sent via SEAP at least 18 days before the offer submission deadline, with answers within 11 days.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile5 open tenders right now
- Procurement of medical supplies for the Emergency Department 1 day left
- Current repair and maintenance works on the facade of Pavilion SM2 2 days left
- Reagents needed for the operation of the bacteriology - immunology department of the medical analysis laboratory - 3 lots 9 days left
Recent awards
Similar tenders
1
day left
€169,005
est. value
1
day left
€616,850
est. value
1
day left
€172,767,852
est. value
1
day left
€2,071,619
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,020,608
- Buyer track record on Aperlena
- 77 notices tracked · 40 awarded
- €1,929,196 in awarded contracts
Never miss a tender like this
320 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alert